1.
Blood
; 130(14): 1671-1674, 2017 10 05.
Article
in English
| MEDLINE
| ID: mdl-28798157
Subject(s)
Anemia, Aplastic/genetics , Bone Marrow Diseases/genetics , Hemoglobinuria, Paroxysmal/genetics , Pregnancy Complications, Hematologic/genetics , Pregnancy Outcome , Abortion, Spontaneous/epidemiology , Abortion, Spontaneous/etiology , Adult , Anemia, Aplastic/complications , Anemia, Aplastic/diagnosis , Anemia, Aplastic/therapy , Bone Marrow Diseases/complications , Bone Marrow Diseases/diagnosis , Bone Marrow Diseases/therapy , Bone Marrow Failure Disorders , False Negative Reactions , Female , Fetal Death/etiology , Hemoglobinuria, Paroxysmal/complications , Hemoglobinuria, Paroxysmal/diagnosis , Hemoglobinuria, Paroxysmal/therapy , Humans , Infant, Newborn , Infertility, Female/etiology , Lactation Disorders/etiology , Pregnancy , Pregnancy Complications, Hematologic/diagnosis , Pregnancy Complications, Hematologic/therapy , RNA/genetics , Registries , Telomerase/genetics , United States/epidemiology
2.
Blood Adv
; 1(19): 1491-1494, 2017 Aug 22.
Article
in English
| MEDLINE
| ID: mdl-29296790
ABSTRACT
cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy.Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.
